HIVE counsel reports options and RSU holdings
HIVE Digital Technologies Ltd. General Counsel Gabriel Ibghy filed an initial ownership report showing existing equity awards and stock holdings.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
HIVE Digital Technologies Ltd. General Counsel Gabriel Ibghy filed an initial ownership report showing existing equity awards and stock holdings. The filing lists options to buy common stock at exercise prices of $13.22, $4.08, and $4.94 per share, plus multiple blocks of restricted stock units, many of which are fully vested. It also notes direct ownership of 3,908 common shares, giving a snapshot of his current equity position with the company.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Ibghy Gabriel
Role
General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Options (right to buy) | -- | -- | -- |
| Holding | Options (right to buy) | -- | -- | -- |
| Holding | Options (right to buy) | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings:
Options (right to buy) — 120,400 contracts (Direct);
Restricted Stock Units — 1,250,614 contracts (Direct);
Common Stock — 3,908 shares (Direct)
Footnotes (15)
- F1. These options were granted on April 29, 2021 and are fully vested as of the date hereof.
- F2. Represents an exercise price of $18.35 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.
- F3. These options were granted on August 6, 2022 and are fully vested as of the date hereof.
- F4. Represents an exercise price of $5.66 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.
- F5. These options were granted on July 6, 2023 and are fully vested as of the date hereof.
- F6. Represents an exercise price of $6.86 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.
- F7. Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock. The RSUs were issued on August 26, 2022 and are fully vested as of the date hereof.
- F8. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on January 5, 2024 and are fully vested as of the date hereof.
- F9. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 18, 2024 and are fully vested as of the date hereof.
- F10. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on November 5, 2024, and 75,000 have vested, with the remaining 45,000 vesting in 3 equal installments on May 5, 2026, August 5, 2026, and November 5, 2026.
- F11. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on February 14, 2025 and are fully vested as of the date hereof.
- F12. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on April 17, 2025 and will vest in one installment on April 17, 2026.
- F13. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 8, 2025 and will vest in one installment on July 8, 2026.
- F14. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on October 31, 2025 and will vest in one installment on October 31, 2026.
- F15. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on March 16, 2026 and will vest in one installment on March 16, 2027.
Key Figures
Stock options grant: 20,000 shares at $13.22
Stock options grant: 50,400 shares at $4.08
Stock options grant: 50,000 shares at $4.94
+4 more
7 metrics
Stock options grant
20,000 shares at $13.22
Options (right to buy) expiring April 29, 2031
Stock options grant
50,400 shares at $4.08
Options (right to buy) expiring August 26, 2027
Stock options grant
50,000 shares at $4.94
Options (right to buy) expiring July 6, 2028
RSU award
50,400 RSUs
Issued August 26, 2022, fully vested
RSU award
205,652 RSUs
Fully vested as of reporting date
RSU vesting schedule
45,000 RSUs
Vest in three equal installments in 2026
Common shares held
3,908 shares
Directly owned common stock
Key Terms
Restricted Stock Unit ("RSU"), exercise price, fully vested, vesting in 3 equal installments, +1 more
5 terms
Restricted Stock Unit ("RSU") financial
"Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share"
exercise price financial
"Represents an exercise price of $18.35 Canadian dollars, converted to U.S. dollars"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
fully vested financial
"These options were granted on April 29, 2021 and are fully vested as of the date hereof"
vesting in 3 equal installments financial
"75,000 have vested, with the remaining 45,000 vesting in 3 equal installments"
exercise date financial
"exercise date: null, expiration date: 2031-04-29T00:00:00.000Z"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the HIVE Form 3 filing by Gabriel Ibghy show?
The Form 3 shows that HIVE’s General Counsel, Gabriel Ibghy, already holds options, restricted stock units, and 3,908 common shares. It is an initial ownership report, listing his existing equity position rather than recording any new buy or sell transactions.
How many stock options does HIVE’s General Counsel report on Form 3?
The filing lists options over 20,000 shares at a $13.22 exercise price, 50,400 shares at $4.08, and 50,000 shares at $4.94. Footnotes state these option grants from 2021, 2022, and 2023 are fully vested as of the reporting date.
What restricted stock units (RSUs) are disclosed for HIVE’s General Counsel?
The Form 3 reports multiple RSU awards, including blocks of 50,400, 14,562, 205,652, 120,000, 60,000 and several 200,000-share grants. Footnotes explain each RSU converts into one common share at settlement, with some grants fully vested and others vesting through 2027.
Are the HIVE options and RSUs held by Gabriel Ibghy vested?
Footnotes state the 2021, 2022, and 2023 option grants are fully vested. Several RSU grants from 2022, 2024, and early 2025 are also fully vested, while later RSU awards vest on specific dates in 2026 and 2027 as described in the filing.
Does the HIVE Form 3 show any insider buying or selling activity?
No buy or sell transactions are indicated. The entries are classified as holdings with unknown transaction codes, and the transaction summary shows zero buys, zero sells, and 13 holding entries, meaning the document simply reports existing positions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
